Approval · Notice of Compliance 25735 · 2021
REACTINE FAST MELT JUNIOR: Notice of Compliance 25735
Issued April 22, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25735
- Date
- April 22, 2021
- Company
- McNeil Consumer Healthcare, division of Johnson & Johnson Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revise labelling to provide clarity on use in the pediatric population
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE FAST MELT JUNIOR | 02358352 | Marketed |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 10 MG per TAB